• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性血管性水肿患儿与组胺能血管性水肿患者的健康相关生活质量比较。

Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema.

机构信息

From the Department of Pediatric Allergy, Hacettepe University Faculty of Medicine, Ankara, Turkey; and.

Department of Pediatric Allergy, Sanliurfa Training and Research Hospital, Sanliurfa, Turkey.

出版信息

Allergy Asthma Proc. 2021 Jul 1;42(4):325-332. doi: 10.2500/aap.2021.42.210019.

DOI:10.2500/aap.2021.42.210019
PMID:34187624
Abstract

Hereditary angioedema (HAE) is a potentially life-threatening disease that remarkably impacts patients' health-related quality of life (HRQoL). This study evaluated the HRQoL in children with HAE and compared it with healthy controls and patients with histaminergic angioedema (HA). Fifty-nine children with HAE (median [interquartile range {IQR}], ages, 8.9 years [5.4-12.6 years]), 60 children with HA (median [IQR] ages, 10.3 years [8-15.4 years]), and 72 healthy controls (median [IQR] ages, 10.3 years [6.6-13.9 years]) were recruited. All the children and their families completed the age-adapted KINDL generic instrument for assessing health-related quality of life in children and adolescents. The total HRQoL score and other subscales scores of both the patients with HAE and patients with HA, and the parent-proxy reports were significantly lower than those of the healthy children (p < 0.05). In the patients with HAE, the age at symptom onset was positively correlated with physical well-being (r = 0.335; = 0.043) and negatively correlated with self-esteem ( = -0.324; = 0.049). In addition, the physical well-being scores were affected by the site of attacks, which was significantly lower in the patients with abdominal pain attacks ( = 0.045). The family scores and total scores were statistically significantly higher in the HA group than the HAE group ( < 0.001 and = 0.009, respectively). A significant correlation was found between self-report and parent-proxy HRQoLs in total and all subscales scores in the patients with HAE. For HA, there were no significant correlations for family scores. HAE caused significant impairment of the HRQoL of children and their families, and affected their lifestyle and quality of life. In pediatric patients with HAE, the HRQoL is mainly related to age at symptom onset and the site of attacks. Although patients with HAE are affected more negatively than the patients with HA, HA affected the quality of life as well.

摘要

遗传性血管性水肿(HAE)是一种潜在危及生命的疾病,极大地影响患者的健康相关生活质量(HRQoL)。本研究评估了 HAE 患儿的 HRQoL,并与健康对照和组胺能血管性水肿(HA)患者进行了比较。共招募了 59 例 HAE 患儿(中位数[四分位距{IQR}],年龄 8.9 岁[5.4-12.6 岁])、60 例 HA 患儿(中位数[IQR],年龄 10.3 岁[8-15.4 岁])和 72 名健康对照(中位数[IQR],年龄 10.3 岁[6.6-13.9 岁])。所有儿童及其家属均完成了适合年龄的 KINDL 通用量表,用于评估儿童和青少年的健康相关生活质量。HAE 患儿和 HA 患儿的总 HRQoL 评分和其他各分量表评分以及父母代理报告均显著低于健康儿童(p < 0.05)。在 HAE 患儿中,症状发作年龄与身体幸福感呈正相关(r = 0.335;p = 0.043),与自尊呈负相关( = -0.324;p = 0.049)。此外,攻击部位会影响身体幸福感评分,腹痛发作的患儿评分显著较低(p = 0.045)。HA 组的家庭评分和总分均显著高于 HAE 组(p < 0.001 和 p = 0.009)。HAE 患儿的自我报告和父母代理 HRQoL 总分及各分量表评分均存在显著相关性。HA 组在家庭评分方面无显著相关性。HAE 导致儿童及其家属的 HRQoL 显著受损,并影响其生活方式和生活质量。在 HAE 儿科患者中,HRQoL 主要与症状发作年龄和攻击部位有关。虽然 HAE 患者受影响比 HA 患者更严重,但 HA 也会影响生活质量。

相似文献

1
Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema.遗传性血管性水肿患儿与组胺能血管性水肿患者的健康相关生活质量比较。
Allergy Asthma Proc. 2021 Jul 1;42(4):325-332. doi: 10.2500/aap.2021.42.210019.
2
Health-related quality of life among children with hereditary angioedema.遗传性血管性水肿患儿的健康相关生活质量
Pediatr Allergy Immunol. 2017 Jun;28(4):370-376. doi: 10.1111/pai.12712. Epub 2017 Apr 4.
3
Health-related quality of life in Danish children with hereditary angioedema.丹麦遗传性血管性水肿患儿的健康相关生活质量
Allergy Asthma Proc. 2017 Nov 1;38(6):440-446. doi: 10.2500/aap.2017.38.4093.
4
Recurrent angioedema in childhood: hereditary angioedema or histaminergic angioedema?儿童复发性血管性水肿:遗传性血管性水肿还是组胺能性血管性水肿?
Pediatr Dermatol. 2021 Jan;38(1):143-148. doi: 10.1111/pde.14467. Epub 2020 Dec 4.
5
The relationship between anxiety and quality of life in children with hereditary angioedema.遗传性血管性水肿患儿焦虑与生活质量的关系。
Pediatr Allergy Immunol. 2017 Nov;28(7):692-698. doi: 10.1111/pai.12758. Epub 2017 Aug 11.
6
Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States.患者报告遗传性血管性水肿负担:来自美国患者调查的结果。
Ann Allergy Asthma Immunol. 2020 Jun;124(6):600-607. doi: 10.1016/j.anai.2020.02.018. Epub 2020 Mar 10.
7
Health-related quality of life and its risk factors in Chinese hereditary angioedema patients.中国遗传性血管性水肿患者的健康相关生活质量及其危险因素。
Orphanet J Rare Dis. 2019 Aug 8;14(1):191. doi: 10.1186/s13023-019-1159-5.
8
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.用于预防遗传性血管性水肿发作的皮下 C1 抑制剂的健康相关生活质量。
J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1733-1741.e3. doi: 10.1016/j.jaip.2017.12.039. Epub 2018 Jan 31.
9
Effect of COVID-19 on hereditary angioedema activity and quality of life.COVID-19 对遗传性血管性水肿活动和生活质量的影响。
Allergy Asthma Proc. 2021 Sep 1;42(5):403-408. doi: 10.2500/aap.2021.42.210066.
10
National audit of a hereditary and acquired angioedema cohort in New Zealand.新西兰遗传性和获得性血管性水肿队列的全国性审计。
Intern Med J. 2022 Dec;52(12):2124-2129. doi: 10.1111/imj.15466. Epub 2022 Jul 21.

引用本文的文献

1
Hereditary angioedema in children: Review and practical perspective for clinical management.儿童遗传性血管性水肿:临床管理的综述与实践视角
Pediatr Allergy Immunol. 2024 Dec;35(12):e14268. doi: 10.1111/pai.14268.
2
Clinical Characteristics and Quality of Life in a Cohort of Polish Pediatric Patients with Hereditary Angioedema.一组波兰遗传性血管性水肿儿科患者的临床特征与生活质量
Children (Basel). 2024 Feb 13;11(2):237. doi: 10.3390/children11020237.
3
Asthma biomarkers and COVID-19 continue to dominate current medical issues.哮喘生物标志物与新冠病毒病仍是当前医学领域的主要议题。
Allergy Asthma Proc. 2022 Sep 1;43(5):363-367. doi: 10.2500/aap.2022.43.220062.
4
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist.长期新冠与嗅觉丧失:一种新冠后嗅觉功能障碍,持续给过敏症专科医生/免疫学家带来挑战。
Allergy Asthma Proc. 2022 Mar 1;43(2):93-95. doi: 10.2500/aap.2022.43.220008.
5
Evaluation and management of adverse reactions to the COVID-2019 vaccines.2019冠状病毒病疫苗不良反应的评估与管理
Allergy Asthma Proc. 2022 Jan 1;43(1):1-4. doi: 10.2500/aap.2022.43.210118.